Toggle light / dark theme

A team of researchers from Yale and the University of Connecticut (UConn) has developed a nanoparticle-based treatment that targets multiple culprits in glioblastoma, a particularly aggressive and deadly form of brain cancer.

The results are published in Science Advances (“Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy”).

A new treatment developed by Yale researchers uses bioadhesive nanoparticles that adhere to the site of the tumor and then slowly release the synthesized peptide nucleic acids that they’re carrying. In this image, the nanoparticles (red) are visible within human glioma tumor cells (green with blue nuclei). (Image: Yale Cancer Center)

For copyright contact: stienlemane2379(at)gmail.com.

Welcome to Futureunity, where we explore the fascinating world of science, technology, and the universe! From the inner workings of the human body to the outer reaches of space, we delve into the latest and most interesting discoveries that are shaping our world. Whether you’re a science buff or just looking for some mind-blowing facts, we’ve got you covered. Join us as we uncover the mysteries of the world around us and discover new frontiers in the fields of science and technology. Get ready for a journey that’s both educational and entertaining!

Disclaimer Fair Use:
1. The videos have no negative impact on the original works.
2. The videos we make are used for educational purposes.
3. The videos are transformative in nature.
4. We use only the audio component and tiny pieces of video footage, only if it’s necessary.
Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research. Fair use is a use permitted by copyright statutes that might otherwise be infringing.

Disclaimer:

Dr. Nick Melosh at the BrainMind Summit hosted at Stanford, interviewed by BrainMind member Christian Bailey.

Nick Melosh is a Professor of Materials Science and Engineering, Stanford University. Nick’s research at Stanford focuses on how to design new inorganic structures to seamlessly integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano-and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.”

Learn more about BrainMind: https://brainmind.org/
Apply to BrainMind: https://brainmind.org/application

Gabriel Kreiman is a Professor at Harvard Medical School. He is on faculty at Children’s Hospital and the Center for Brain Science at Harvard University. He is Associate Director and Thrust Leader in the Harvard/MIT Center for Brains, Minds, and Machines. He received his MSc and PhD from the California Institute of Technology and pursued postdoctoral work with Professor Poggio at MIT.

The Kreiman laboratory combines behavioral metrics, neurophysiological recordings and computational models to understand cognitive function and to build biologically inspired Artificial Intelligence systems. Kreiman’s work has focused on two main themes: understanding the transformation of pixel-like inputs into rich and complex visual percepts; and elucidating the subjectively filters incoming inputs to create lasting narratives that constitute the fabric of our personal experiences and knowledge.

In 1959, Richard Feynman made the famous assertion that one day we will be able to swallow the surgeon. Advancements in nanomedicine are making that dream come true. Nanoroboticist Metin Sitti shows the tiny robot that can take pictures, biopsy, and deliver medicine inside of you.

Watch the full program here: https://youtu.be/FzFY5ms3AUc.
Original program date: May 30, 2013

The World Science Festival gathers great minds in science and the arts to produce live and digital content that allows a broad general audience to engage with scientific discoveries. Our mission is to cultivate a general public informed by science, inspired by its wonder, convinced of its value, and prepared to engage with its implications for the future.

Visit our Website: http://www.worldsciencefestival.com/

Science fiction has become a reality with recent developments toward biohacking through nanotechnology. Soon, science and industries may soon realize the potential of human hacking… but at what risk versus reward? Medical nanotechnology is one of these such topics. Many experts believe nanotechnology will pave the way for a bright, new future in improving our wellbeing. Yet, at the core of this biohacking are machines and as we’ve seen with other technologies — there are very real risks of malicious intent. In this video, we share some of the applications being developed combining nanotechnology and medicine. We also look at the potential risks found in the practice and how we may mitigate issues before they’re problematic. We also share how companies can reduce security flaws and curb public perception so the nanotechnology industry can flourish without major setbacks. Want to learn more about this budding area of science and medicine?

See our accompanying blog post for the details and be sure to dig around the site, here:

Hacking Humans with Nanotechnology

#nanotech #nanotechhacking

Many of the proteins that play a crucial role in living cells adhere to a core principle of biology: their form, or shape, fits their function. But there is also a vast number of proteins and their parts that defy that dogma.

Why it matters: New findings are revealing how these flexible, disordered proteins work — and deciphering their role in human diseases and potential treatments.

How it works: Whether many medicines, immune cells, or the moment-to-moment inner workings of cells function depends on the shape of proteins they interact with or use.

Top 10 upcoming future technologies | trending technologies | 10 upcoming tech.

Future technologies are currently developing at an acclerated rate. Future technology ideas are being converted into real life at a very fast pace.

These Innovative techs will address global challenges and at the same time will make life simple on this planet. Let’s get started and have a look at the top technologies of the future | Emerging technologies.

#futuretechnologies #futuretech #futuristictechnologys #emergingtechnologies #technology #tech #besttechnology #besttech #newtechnology #cybersecurity #blockchain #emergingtech #futuretechnologyideas #besttechnologies #innovativetechs.

The organoids can be used to study the development of diseases and the effects of drugs.

Michael Helmrath, a pediatric surgeon at Cincinnati Children’s Hospital Medical Center, and his colleagues made headlines last week when they revealed trials where they had transplanted balls of human intestinal tissue into mice, according to a report by *Wired* published on Thursday.

After a few weeks, these transplants developed key features of the human immune system, introducing a model that could be used to effectively simulate the human intestinal system.

It’s not the first time researchers at Cincinnati Children’s make such an advancement in organoids (miniature replicas of human organs). In 2010, the institution became the first in the world to create a working intestinal organoid. ## Containing human cells

Since organoids contain human cells and exhibit some of the same structures and functions as real organs, scientists everywhere are using them to study how organs develop, how diseases occur and how drugs work.

A powerful plant-derived toxin with a unique way of killing harmful bacteria has been identified as one of the most promising new antibiotics in decades.

Albicidin, a new antibiotic, is produced by the plant pathogen Xanthomonas albilineans, responsible for causing sugar cane’s destructive leaf scald disease. The toxin is believed to aid the pathogen’s spread by attacking the plant. Albicidin has been shown to be highly effective against harmful bacteria, including drug-resistant superbugs such as E. coli and S. aureus.

Despite its antibiotic potential and low toxicity in pre-clinical experiments, pharmaceutical development of albicidin has been hampered because scientists did not know precisely how it interacted with its target, the bacterial enzyme DNA.